Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Schizophrenia

In brief

The main objective of the study is to evaluate NBI-1117568 compared with placebo in delaying relapse of symptoms of schizophrenia in adults who have a stable response after open-label treatment with NBI-1117568.

Key facts

Study ID

NCT07227818

Run by

Neurocrine Biosciences

People needed

560

Starts

2025-12-16

Expected to finish

2029-07-01

Last updated by the study team

2026-06-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Neurocrine Clinical Site — Garden Grove, California, United States (enrolling)
• Neurocrine Clinical Site — La Habra, California, United States (enrolling)
• Neurocrine Clinical Site — Lemon Grove, California, United States (enrolling)
• Neurocrine Clinical Site — Oceanside, California, United States (enrolling)
• Neurocrine Clinical Site — Torrance, California, United States (enrolling)
• Neurocrine Clinical Site — West Hills, California, United States (enrolling)
• Neurocrine Clinical Site — Hollywood, Florida, United States (enrolling)
• Neurocrine Clinical Site — Maitland, Florida, United States (enrolling)
• Neurocrine Clinical Site — Miami, Florida, United States (enrolling)
• Neurocrine Clinical Site — Miami, Florida, United States (enrolling)
• Neurocrine Clinical Site — Tampa, Florida, United States (enrolling)
• Neurocrine Clinical Site — West Palm Beach, Florida, United States (enrolling)
• Neurocrine Clinical Site — Atlanta, Georgia, United States (enrolling)
• Neurocrine Clinical Site — Boston, Massachusetts, United States (enrolling)
• Neurocrine Clinical Site — Flowood, Mississippi, United States (enrolling)
• Neurocrine Clinical Site — Cedarhurst, New York, United States (enrolling)
• Neurocrine Clinical Site — New York, New York, United States (enrolling)
• Neurocrine Clinical Site — New York, New York, United States (enrolling)
• Neurocrine Clinical Site — The Bronx, New York, United States (enrolling)
• Neurocrine Clinical Site — Bellevue, Washington, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.